For citations:
Matveev V.B., Kirichek A.A., Savinkova A.V., Khachaturyan A.V., Golovina D.A., Lyubchenko L.N. Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer. Cancer Urology. 2018;14(4):53-67. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-4-53-67
Email this article 